¼±Åà - È»ìǥŰ/¿£ÅÍŰ
´Ý±â - ESC
KMLE °Ë»ö
°Ë»ö ¼³Á¤
¿Â¶óÀÎ ÀÇÇмÀû
ÀÇÇпë¾î »çÀü
ÀÇÇоà¾î
ÀÇÇлçÀü
ÇÑ¿µ/¿µÇÑ»çÀü
¿µ¿µ»çÀü
»çÀÌÆ® ¼Ò°³
Àç°Ë»ö
"cell interaction"¿¡ ´ëÇÑ ´ëÇÑÀÇÇù ÀÇÇпë¾î ¼¼ºÎ °Ë»ö °á°úÀÔ´Ï´Ù
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
cell interaction
¼¼Æ÷»óÈ£ÀÛ¿ë
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
antigen-antibody interaction
Ç׿øÇ×ü»óÈ£ÀÛ¿ë
additive interaction
»ó°¡ÀÛ¿ë
binocular interaction
µÎ´«»óÈ£ÀÛ¿ë, ¾ç¾È»óÈ£ÀÛ¿ë
drug interaction
¾à¹°»óÈ£ÀÛ¿ë
dipolar interaction
½Ö±ØÀÚ»óÈ£ÀÛ¿ë
genetic interaction
À¯Àü»óÈ£ÀÛ¿ë
infant-mother interaction
¿µ¾Æ¾ö¸¶»óÈ£ÀÛ¿ë
interaction
»óÈ£ÀÛ¿ë
orbit interaction
±Ëµµ»óÈ£ÀÛ¿ë
primary interaction
ÀÏÂ÷»óÈ£ÀÛ¿ë
receptor-ligand interaction
¼ö¿ëü¸®°£µå»óÈ£ÀÛ¿ë
radiation interaction
¹æ»ç¼±»óÈ£ÀÛ¿ë
simple interaction
´Ü¼ø»óÈ£ÀÛ¿ë
acantholytic cell
°¡½Ã¼¼Æ÷ºÐ¸®¼¼Æ÷
angioimmunoblastic T-cell lymphoma
Ç÷°ü¸é¿ª¸ð±¸T¼¼Æ÷¸²ÇÁÁ¾
´ÙÀ½
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
interaction
»óÈ£ÀÛ¿ë
sickle cell anemia
³´ÀûÇ÷±¸ºóÇ÷
cell
¼¼Æ÷
accessory cell
º¸Á¶¼¼Æ÷, µ¡¼¼Æ÷
acinar cell
»ù²Ê¸®¼¼Æ÷
amacrine cell
¹«Ãà»è¼¼Æ÷
balloon cell
dz¼±¼¼Æ÷
basal cell
¹Ù´Ú¼¼Æ÷, ±âÀú¼¼Æ÷
basal cell carcinoma
¹Ù´Ú¼¼Æ÷¾ÏÁ¾, ±âÀú¼¼Æ÷¾ÏÁ¾
basket cell
¹Ù±¸´Ï¼¼Æ÷
basophilic cell
È£¿°±â¼¼Æ÷
beta cell
º£Å¸¼¼Æ÷
bipolar cell
µÎ±Ø¼¼Æ÷
blood cell
Ç÷¾×¼¼Æ÷, Ç÷±¸
ethmoidal cell
¹úÁý»À¹úÁý
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
cell interaction
¼¼Æ÷»óÈ£ÀÛ¿ë
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
additive interaction
»ó°¡ÀÛ¿ë
antigen-antibody interaction
Ç׿øÇ×ü¹ÝÀÀ
binocular interaction
¾ç¾È»óÈ£ÀÛ¿ë, µÎ´«»óÈ£ÀÛ¿ë
dipolar interaction
½Ö±ØÀÚ»óÈ£ÀÛ¿ë
drug interaction
¾à¹°»óÈ£ÀÛ¿ë
genetic interaction
À¯Àü»óÈ£ÀÛ¿ë
interaction
»óÈ£ÀÛ¿ë
infant-mother interaction
¿µ¾Æ¾ö¸¶»óÈ£ÀÛ¿ë
orbit interaction
±Ëµµ»óÈ£ÀÛ¿ë
primary interaction
ÀÏÂ÷»óÈ£ÀÛ¿ë
radiation interaction
¹æ»ç¼±»óÈ£ÀÛ¿ë
receptor-ligand interaction
¼ö¿ëü¹èÀ§ÀÚ»óÈ£ÀÛ¿ë
simple interaction
´Ü¼ø»óÈ£ÀÛ¿ë
tissue interaction
Á¶Á÷»óÈ£ÀÛ¿ë
acantholytic cell
°¡½Ã¼¼Æ÷ÇØ¸®¼¼Æ÷
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
abnormality of cell interaction
¼¼Æ÷»óÈ£ÀÛ¿ëÀÌ»ó
interaction, T-B cell
T¼¼Æ÷-B¼¼Æ÷ »óÈ£ÀÛ¿ë
interaction, T-T cell
T¼¼Æ÷°£ »óÈ£ÀÛ¿ë
J-coupling interaction
J °áÇÕ »óÈ£ÀÛ¿ë
additive interaction
»ó°¡(ßÓÊ¥)ÀÛ¿ë.
antigen antibody interaction
Ç׿øÇ×ü»óÈ£¹ÝÀÀ.
antigen antibody interaction
Ç׿øÇ×ü»óÈ£¹ÝÀÀ.
antigen antibody interaction
Ç׿øÇ×ü»óÈ£¹ÝÀÀ.
antigen-antibody interaction
Ç׿ø-Ç×ü»óÈ£ÀÛ¿ë
genetic interaction
À¯ÀüÀû »óÈ£ÀÛ¿ë
heme heme interaction
Èû-Èû »óÈ£ÀÛ¿ë(¡ßÓû»íÂéÄ).
heme heme interaction
Çð-Çð »óÈ£ÀÛ¿ë(¡ßÓû»íÂéÄ).
infant-mother interaction
¿µ¾Æ-¸ð »óÈ£ÀÛ¿ë
interaction
»óÈ£ÀÛ¿ë(ßÓû»íÂéÄ).
interaction
»óÈ£ÀÛ¿ë
´ÙÀ½
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
1
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
cell interaction
¼¼Æ÷»óÈ£ÀÛ¿ë
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú :
15
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
abnormality of cell interaction
¼¼Æ÷»óÈ£ÀÛ¿ëÀÌ»ó
interaction, T-B cell
T¼¼Æ÷-B¼¼Æ÷ »óÈ£ÀÛ¿ë
interaction, T-T cell
T¼¼Æ÷°£ »óÈ£ÀÛ¿ë
additive interaction
»ó°¡(ßÓÊ¥)ÀÛ¿ë.
antigen antibody interaction
Ç׿øÇ×ü»óÈ£¹ÝÀÀ.
antigen antibody interaction
Ç׿øÇ×ü»óÈ£¹ÝÀÀ.
antigen antibody interaction
Ç׿øÇ×ü»óÈ£¹ÝÀÀ.
antigen-antibody interaction
Ç׿ø-Ç×ü»óÈ£ÀÛ¿ë
binocular interaction
¾ç¾È»óÈ£ÀÛ¿ë
cellular interaction
¼¼Æ÷»óÈ£ÀÛ¿ë
dipolar interaction
½Ö±ØÀÚ»óÈ£ÀÛ¿ë
dipole dipole interaction
½Ö±ØÀÚ ½Ö±ØÀÚ »óÈ£ÀÛ¿ë
drug interaction
¾à¹° »óÈ£ÀÛ¿ë
drug interaction
¾à¹°»óÈ£ÀÛ¿ë.
drug interaction
¾à¹°»óÈ£ÀÛ¿ë(å·ÚªßÓû»íÂéÄ).
´ÙÀ½
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú :
0
ÆäÀÌÁö:
1
¿µ¹®
ÇѱÛ
ÅëÇÕ°Ë»ö ¿Ï·á
´ÙÀ½